Pony Group Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Pony Group Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $141.4K | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | $97.4K | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | $177.6K | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | $114.3K | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $157.6K | Jun 30, 2023 |
| FY2021 | Dec 31, 2020 | $115.4K | Apr 11, 2023 |
| FY2020 | Dec 31, 2019 | $65.1K | Aug 3, 2021 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $47.4K | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | $41.9K | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | $81.5K | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | $37.2K | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $55.3K | Jun 30, 2023 |
| FY2021 | Dec 31, 2020 | $57.2K | Apr 11, 2023 |
| FY2020 | Dec 31, 2019 | $11.9K | Aug 3, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($246.4K) | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | ($164.1K) | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | ($148.5K) | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | ($284.0K) | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | ($98.0K) | Jun 30, 2023 |
| FY2021 | Dec 31, 2020 | ($41.8K) | Apr 11, 2023 |
| FY2020 | Dec 31, 2019 | ($115.7K) | Aug 3, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($245.7K) | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | ($163.0K) | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | ($147.8K) | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | ($285.5K) | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | ($116.0K) | Jun 30, 2023 |
| FY2021 | Dec 31, 2020 | ($43.6K) | Apr 11, 2023 |
| FY2020 | Dec 31, 2019 | ($117.7K) | Aug 3, 2021 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $23.8K | Jun 30, 2023 |
| FY2022 | Dec 31, 2021 | $10.5K | Jun 30, 2023 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($101.3K) | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | ($149.0K) | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | ($152.9K) | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | ($321.3K) | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | ($2.8K) | Jun 30, 2023 |
| FY2021 | Dec 31, 2020 | ($61.1K) | Apr 11, 2023 |
| FY2020 | Dec 31, 2019 | ($115.7K) | Aug 3, 2021 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $22.1K | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | $17.1K | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | $37.1K | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | $107.3K | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $323.1K | Jun 30, 2023 |
| FY2021 | Dec 31, 2020 | $336.8K | Apr 11, 2023 |
| FY2020 | Dec 31, 2019 | $101.6K | Aug 3, 2021 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $974.5K | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | $692.5K | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | $555.2K | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | $482.8K | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $426.1K | Jun 30, 2023 |
| FY2021 | Dec 31, 2020 | $338.0K | Apr 11, 2023 |
| FY2020 | Dec 31, 2019 | $233.7K | Aug 3, 2021 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($952.4K) | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | ($675.4K) | Mar 27, 2026 |
| FY2025 | Dec 31, 2023 | ($518.1K) | Mar 27, 2026 |
| FY2024 | Dec 31, 2022 | ($375.5K) | Mar 27, 2025 |
| FY2023 | Dec 31, 2021 | ($102.7K) | Mar 28, 2024 |
| FY2022 | Dec 31, 2020 | ($1.1K) | Jun 30, 2023 |
| FY2021 | Dec 31, 2019 | ($132.1K) | Apr 11, 2023 |
| FY2020 | Dec 31, 2018 | ($23.5K) | Aug 3, 2021 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.13M) | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | ($888.5K) | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | ($724.4K) | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | ($575.9K) | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | ($280.3K) | Jun 30, 2023 |
| FY2021 | Dec 31, 2020 | ($182.3K) | Apr 11, 2023 |
| FY2020 | Dec 31, 2019 | ($140.5K) | Aug 3, 2021 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.7K | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | $11.0K | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | $16.6K | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | $34.0K | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $266.0K | Jun 30, 2023 |
| FY2021 | Dec 31, 2020 | $287.0K | Apr 11, 2023 |
| FY2020 | Dec 31, 2019 | $44.1K | Aug 3, 2021 |
| FY2020 | Dec 31, 2018 | $10.8K | Aug 3, 2021 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Jun 30, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Apr 11, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Jun 30, 2023 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 11.50M | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | 11.50M | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | 11.50M | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | 11.50M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | 11.50M | Jun 30, 2023 |
| FY2021 | Dec 31, 2020 | 11.50M | Apr 11, 2023 |
| FY2020 | Dec 31, 2019 | 9.00M | Aug 3, 2021 |